Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.31%30.35B | 5.93%30.26B | 7.81%8.01B | 2.95%7.44B | 8.12%7.55B | 4.81%7.26B | 21.67%28.57B | 19.71%7.43B | 3.16%7.23B | 39.49%6.98B |
| Cost of revenue | -0.40%11.43B | 6.73%11.48B | 10.02%3.01B | 4.24%2.85B | 7.70%2.88B | 4.90%2.74B | 19.33%10.75B | 17.79%2.74B | 4.66%2.73B | 34.78%2.67B |
| Gross profit | 0.74%18.92B | 5.45%18.78B | 6.53%5B | 2.17%4.6B | 8.37%4.67B | 4.76%4.52B | 23.13%17.81B | 20.87%4.69B | 2.27%4.5B | 42.58%4.31B |
| Operating expense | 0.82%17.46B | -3.33%17.32B | -0.92%4.37B | -1.25%4.33B | -4.23%4.37B | -6.77%4.25B | 6.13%17.92B | -0.16%4.41B | -1.75%4.39B | 14.17%4.56B |
| Operating profit | -0.29%1.46B | 1,526.10%1.46B | 121.29%632.76M | 134.72%265.26M | 222.94%305.31M | 203.01%260.92M | 95.75%-102.68M | 153.82%285.94M | 272.78%113.01M | 74.39%-248.34M |
| Net non-operating interest income (expenses) | -15.08%-139.97M | 0.86%-121.64M | -2.06%-28.87M | -15.98%-35.6M | 11.42%-28.11M | 9.14%-29.05M | -4.87%-122.7M | 6.55%-28.29M | 0.23%-30.7M | -8.91%-31.74M |
| Non-operating interest income | 70.70%3.27M | -39.27%1.92M | -17.13%629K | -41.81%380K | -31.33%570K | -62.99%339K | -11.22%3.16M | -22.55%759K | -13.40%653K | -17.74%830K |
| Non-operating interest expense | 15.94%143.25M | -1.83%123.55M | 1.56%29.5M | 14.77%35.98M | -11.93%28.68M | -10.64%29.39M | 4.39%125.85M | -7.05%29.05M | -0.54%31.35M | 8.02%32.57M |
| Net investment income | -20.74%3.76M | 54.29%4.75M | 506.44%1.79M | 12.24%1.08M | -5.97%63K | 3.60%1.82M | -38.82%3.08M | -87.92%295K | 13.28%964K | 6.35%67K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 12.81%-383.33M | -20.06%-439.64M | -556.35%-460.5M | -54.24%-54.6M | 85.60%-12.62M | 150.92%88.07M | -284.09%-366.18M | 59.92%-70.16M | -129.30%-35.4M | -183.30%-87.65M |
| Less:Other special charges | 70.99%-18.53M | -153.03%-63.87M | -38.38%11.09M | 7,079.45%17.66M | -83.76%4.26M | -226.61%-96.87M | 239.01%120.45M | -10.45%17.99M | 99.79%-253K | 324.68%26.2M |
| Less:Write off | -20.19%401.86M | 104.91%503.51M | 761.47%449.41M | 3.61%36.94M | -86.39%8.36M | -90.88%8.8M | 35.03%245.73M | -66.33%52.17M | --35.65M | 148.08%61.45M |
| Other non-operating income (expenses) | 224.72%50.14M | -108.55%-40.2M | 24.13%-62.05M | -45.26%11.37M | -173.58%-11.37M | -95.77%21.85M | -86.15%470.48M | -148.60%-81.78M | -98.45%20.76M | -98.11%15.46M |
| Income before tax | 14.18%990.54M | 835.24%867.51M | -21.57%83.14M | 173.16%187.51M | 171.91%253.27M | 476.87%343.6M | -115.19%-117.99M | 118.73%106M | -94.96%68.64M | -66.20%-352.2M |
| Income tax | 500.61%400.94M | -173.68%-100.08M | -5,951.21%-246.34M | -45.22%60.67M | 634.69%53.18M | 137.58%32.4M | -53.76%135.84M | 105.90%4.21M | -58.55%110.76M | 48.55%7.24M |
| Net income | -39.07%589.6M | 481.20%967.6M | 223.67%329.47M | 401.19%126.84M | 155.66%200.08M | 577.61%311.2M | -152.57%-253.83M | 120.59%101.79M | -103.84%-42.11M | -65.80%-359.44M |
| Net income continuous operations | -39.07%589.6M | 481.20%967.6M | 223.67%329.47M | 401.20%126.84M | 155.66%200.08M | 577.61%311.21M | -152.57%-253.83M | 120.59%101.79M | -103.84%-42.11M | -65.80%-359.44M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -39.07%589.6M | 481.20%967.6M | 223.67%329.47M | 401.19%126.84M | 155.66%200.08M | 577.61%311.2M | -152.57%-253.83M | 120.59%101.79M | -103.84%-42.11M | -65.80%-359.44M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -39.07%589.6M | 481.20%967.6M | 223.67%329.47M | 401.19%126.84M | 155.66%200.08M | 577.61%311.2M | -152.57%-253.83M | 120.59%101.79M | -103.84%-42.11M | -65.80%-359.44M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -41.25%127.66 | 465.98%217.28 | 203.23%72.2 | 363.35%25.94 | 155.13%46.35 | 577.75%72.79 | -152.58%-59.37 | 120.59%23.81 | -103.84%-9.85 | -65.82%-84.07 |
| Diluted earnings per share | -41.25%127.66 | 465.98%217.28 | 199.61%71.3361 | 363.35%25.94 | 152.02%43.7311 | 577.75%72.79 | -152.58%-59.37 | 120.59%23.81 | -103.84%-9.85 | -65.82%-84.07 |
| Dividend per share | 15 | |||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |